Forward to: Outsourcing Team

Contract Research Org Monitor
Workflows

Ten agent workflows for the Outsourcing Team — CRO capability assessment, capacity monitoring, pricing intelligence, contract research performance tracking, CDMO evaluation, regulatory track record analysis, therapeutic expertise mapping, geographic coverage assessment, technology platform evaluation, and CRO strategy dashboard — enabling data-driven outsourcing decisions powered by domain intelligence.

These workflows display realistic demo data for demonstration. In production, the agents connect to your real biotech and life sciences data via MCP services or CSV import.
Deployment Options
The entire platform is available as a self-hosted solution or managed service
Self-Hosted
RECOMMENDED FOR ENTERPRISE
Deploy the entire platform on your own infrastructure. Your data never leaves your environment. Bring your own LLM API key (OpenAI, Claude, Gemini) or use local LLMs. Full source code delivered.
Complete source code (Python agents, PHP dashboards, MCP services)
Data stays on your servers — no external data transfer
MCP connectors for your existing data sources, APIs, and internal platforms
Custom integration and onboarding support available
$999
2 AI Agents
5 integration hrs
$1,999
5 AI Agents
10 integration hrs
$3,999
10 AI Agents
20 integration hrs
one-time license + (optional) $999/yr updates
Managed Platform
FOR AGENCIES & TEAMS
We host and operate the platform for you. Upload data or connect your platforms via secure MCP services or using API. No infrastructure management needed.
Fully managed — no DevOps required on your side
Secure data upload or API-based MCP integration
Dashboard access with your own branded login
Automatic updates and new agent releases
$999/mo
2 AI Agents
5 integration hrs
$1,999/mo
5 AI Agents
10 integration hrs
$3,999/mo
10 AI Agents
20 integration hrs
includes hosting, updates & support
* price may be higher in cases of very high AI processing volumes/demands
Both options include MCP services with connectors for your existing data sources, APIs, and internal platforms. Data dictionaries define the schema contract between each agent and your data sources.
See example of production dashboards: Programmatic Trading AI Agent Dashboards →

1CRO Capability Assessment

AI agent monitors CRO company domains to assess service capabilities, therapeutic expertise, geographic coverage, and technology platforms — informing vendor selection and RFP processes.

1
Assess CRO Capabilities
/products/about/case-studiesCountriesOpenPageRank
CRO CAPABILITY ASSESSMENT — TOP 20 EVALUATED ════════════════════════════════════════════════════════ iqvia.com — Full-Service Global CRO /products: Phase 1-4 | Biostatistics | Regulatory | Real World /about: 86,000 employees | 100+ countries /case-studies: 120+ oncology trials managed PageRank: 7.8 SCORE: 95/100 — Top tier for large global Phase 3 medpace.com — Mid-Size Specialist /products: Full-service | Strong in rare disease + oncology /about: 5,800 employees | 40+ countries /case-studies: 95% on-time database lock rate SCORE: 91/100 — Best for mid-size biotech Phase 2-3 novaquest.com — Flexible CRO /products: Phase 2-3 | Adaptive trial design specialty /about: 1,200 employees | 28 countries Domain Age: 3,800 days | PageRank: 4.2 SCORE: 76/100 — Good for adaptive trials, limited geography

2CRO Capacity Intelligence

AI agent monitors CRO domain signals to assess current capacity utilization, hiring patterns, and backlog levels — helping secure capacity before market tightening.

1
Track CRO Capacity Signals
/investors/careers/pressOpenPageRank
CRO CAPACITY INTELLIGENCE ════════════════════════════════════════════════════════ iconplc.com /investors: Backlog $22.8B | Book-to-bill: 1.18x /careers: +24% clinical monitor postings — expanding SIGNAL: Healthy capacity — good availability for new trials pra-health.com (ICON) /investors: Integration complete — unified operations /careers: Selective hiring in CNS + rare disease SIGNAL: Selective capacity — specialty areas tighter CAPACITY OUTLOOK: Global CRA availability: Tightening in APAC, stable in US/EU Booking lead time (large Phase 3): 6-8 months advance RECOMMENDATION: Secure CRO contracts 9+ months ahead

3CRO Pricing Benchmarks

AI agent collects and analyzes CRO pricing signals from domain data to establish cost benchmarks, identify pricing trends, and inform budget planning for clinical programs.

1
Benchmark CRO Pricing
/pricing/investors/productsIAB Categories
CRO PRICING BENCHMARK ANALYSIS ════════════════════════════════════════════════════════ COST PER PATIENT (PHASE 3 ONCOLOGY): Top-tier global CRO: $42,000-58,000/patient Mid-size specialist: $35,000-48,000/patient Regional CRO: $22,000-32,000/patient PRICING TRENDS (YoY CHANGE): Full-service CRO: +8-12% increase Biostatistics: +15% (AI talent competition) Data management: -5% (automation gains) Regulatory writing: +6% increase COST OPTIMIZATION: Hybrid model (global CRO + regional sites): 25% savings Risk-sharing contracts: Available from 3 CROs

4CDMO Evaluation

AI agent monitors contract development and manufacturing organization domains to assess manufacturing capabilities, regulatory track records, and capacity for drug product and drug substance production.

1
Evaluate CDMO Partners
/products/compliance/pressCountries
CDMO EVALUATION — BIOLOGICS MANUFACTURING ════════════════════════════════════════════════════════ lonza.com — Global CDMO Leader /products: Mammalian | Microbial | Cell & Gene Therapy /compliance: All facilities — clean inspection record /press: $1.2B capacity expansion (Singapore + US) SCORE: 96/100 — Premium quality, premium pricing samsung-biologics.com — Large-Scale Biologics /products: 620,000L total bioreactor capacity /compliance: FDA + EMA approved facilities /press: Plant 4 operational — world's largest biomanufacturing SCORE: 93/100 — Best value for large-scale mAb production catalent.com — Diversified CDMO /products: Biologics + cell therapy + gene therapy /compliance: FDA Form 483 at gene therapy facility SCORE: 78/100 — Quality concerns at specific sites

5Regulatory Track Record Analysis

AI agent assesses CRO and CDMO regulatory compliance track records by monitoring inspection outcomes, warning letters, and quality system effectiveness across vendor domains.

1
Assess Regulatory Compliance History
/compliance/press/aboutCountries
VENDOR REGULATORY TRACK RECORD ════════════════════════════════════════════════════════ EXCELLENT TRACK RECORD: parexel.com — 0 FDA observations (last 3 inspections) medpace.com — 1 minor observation (resolved in 30 days) lonza.com — Clean record across all 14 facilities MONITOR CLOSELY: labcorp-dds.com — 3 observations in last inspection /compliance: CAPA plan submitted — resolution pending SIGNAL: Monitor resolution before new contract placement HIGH RISK: emergent-biosolutions.com /compliance: Warning Letter active — Bayview facility SIGNAL: Do not place new work until resolution confirmed

6Therapeutic Expertise Mapping

AI agent maps CRO therapeutic expertise by analyzing case studies, press releases, and career postings to identify which CROs have the deepest experience in specific disease areas.

1
Map CRO Therapeutic Expertise
/case-studies/about/pressIAB Categories
CRO THERAPEUTIC EXPERTISE MAP ════════════════════════════════════════════════════════ CRO Oncology Rare Disease CNS Cardio Gene Tx iqvia.com AAA AA AAA AAA A medpace.com AAA AAA AA AA AA iconplc.com AAA AA AAA AA AA pra-health.com AA AA AAA AA A worldwide-cro.com AA AAA AA A AAA RECOMMENDATION: Gene therapy trials: Worldwide Clinical Trials — deepest CGT expertise Rare disease Phase 3: Medpace — best enrollment track record

7Geographic Coverage Assessment

AI agent analyzes CRO geographic footprints by monitoring office locations, site networks, and regional expertise — informing global trial placement decisions.

1
Assess Geographic Capabilities
/about/contact/careersCountries
CRO GEOGRAPHIC COVERAGE MAP ════════════════════════════════════════════════════════ iqvia.com — Global Presence /about: Offices in 100+ countries /careers: Active postings in 52 countries Strongest: US, EU, Japan, China novotech-cro.com — APAC Specialist /about: 34 offices across Asia-Pacific /careers: Strong presence in AU, KR, TW, SG SCORE: Best APAC coverage for biotech GEOGRAPHIC CAPACITY OUTLOOK: US: Stable — adequate site availability Western EU: Tightening — 6-month lead time APAC: Growing — cost advantage 30-40% Eastern EU: Reduced access — geopolitical risk

8CRO Technology Platform Review

AI agent evaluates CRO technology platforms by monitoring product pages, API documentation, and case studies — assessing EDC, CTMS, eCOA, and AI/ML capabilities.

1
Evaluate CRO Technology Stack
/products/api/docsOpenPageRank
CRO TECHNOLOGY PLATFORM ASSESSMENT ════════════════════════════════════════════════════════ medidata.com (Dassault Systemes) /products: Rave EDC + Detect AI + Sensor Cloud /api: REST API — full integration capability /docs: Comprehensive developer documentation SCORE: 94/100 — Industry-leading clinical technology veeva.com — Vault CTMS /products: Clinical operations platform + eTMF /api: Open API architecture SCORE: 90/100 — Best-in-class CTMS + eTMF TECHNOLOGY TRENDS: AI-powered patient matching: 4 CROs now offering Decentralized trial platforms: Growing 35% YoY Real-time data analytics: Becoming standard expectation

9CRO M&A & Market Consolidation

AI agent tracks CRO industry consolidation — monitoring mergers, acquisitions, and private equity activity that reshape the contract research landscape and vendor options.

1
Track CRO Market Consolidation
/investors/press/leadershipOpenPageRank
CRO MARKET CONSOLIDATION TRACKER ════════════════════════════════════════════════════════ RECENT M&A ACTIVITY: ICON + PRA Health Sciences — $12B merger integrated Thermo Fisher + PPD — Full integration complete Charles River + SAMDI Tech — Screening capability added PENDING / EXPECTED: 2-3 mid-size CRO acquisitions expected H2 2026 PE-backed CROs reaching maturity for exit MARKET IMPACT: Top 5 CROs market share: 68% (up from 55% in 2020) Mid-size CRO options: Declining — fewer choices SIGNAL: Secure preferred vendor agreements before further consolidation

10CRO Strategy Dashboard

AI agent synthesizes all outsourcing intelligence into a dashboard — providing leadership with vendor performance, capacity outlook, and strategic recommendations for clinical operations outsourcing.

1
Generate CRO Strategy Dashboard
/products/investors/careersOpenPageRankCountries
CRO STRATEGY DASHBOARD — FEBRUARY 2026 ════════════════════════════════════════════════════════ VENDOR PORTFOLIO: Active CRO partnerships: 6 | CDMOs: 4 Vendor performance (avg): 87/100 Quality issues: 1 CDMO flagged CAPACITY & COST: CRO market inflation: +8-12% YoY APAC cost advantage: 30-40% savings Lead time for Phase 3: 6-8 months MARKET DYNAMICS: Industry consolidation: Reducing options Technology maturity: AI + DCT improving efficiency
2
Generate CRO Report

CRO Outsourcing Report — February 2026

EXECUTIVE SUMMARY ──────────────────────────────────────── CROs evaluated: 45 organizations CDMOs assessed: 28 facilities Geographic markets analyzed: 52 countries Technology platforms reviewed: 12 systems KEY INSIGHTS CRO market consolidation reducing vendor options — top 5 now 68% share. Pricing inflation 8-12% driven by talent competition and demand. APAC emerging as cost-effective alternative for Phase 2-3 trials. CDMO quality remains critical risk — one vendor flagged for remediation. AI-powered clinical technology becoming standard CRO offering. Recommend securing multi-year framework agreements with top 3 CROs.
Get in Touch

Interested in AI Agent Domain Intelligence?

For pricing, subscription options, custom database builds, or enterprise partnerships — contact us below.

Power Your AI Agents with Domain Intelligence

Subscribe to the AI Agent Domain Database — continuous access to 102M domains, 20 page types each, quarterly refreshes, and real-time change signals.

AI Agent Database View Pricing

Annual subscription includes quarterly data refreshes, change detection alerts, and priority API access.